NCT06141161

Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Asthma is a significant public health threat, affecting more than 300 million individuals globally. Asthma is classified as a non-communicable disease and leads to reduced quality of life, poor physical functioning and reduced emotional well-being. The impact of this disease can be widespread and extends beyond the person living with the disease, affecting the lives of their family members, carers, communities and the health care system (1). Asthma is a variable chronic respiratory condition. It is characterized by symptoms of wheeze, cough, chest tightness, dyspnea and backed by variable airflow limitation, airway inflammation and airway hyper-responsiveness (AHR). The severity of asthma varies considerably, both between individuals and within individuals over time. Some people may have intermittent asthma and others may experience severe, potentially life-threatening disease (2, 3,4).

Conditions

• Bronchial Asthma

Interventions

Type	Name	Description
DRUG	corticosteroids	inhailed or oral corticosteroids

Timeline

• Start date: 2023-11-01
• Primary completion: 2024-12-30
• Completion: 2024-12-30
• First posted: 2023-11-21
• Last updated: 2023-11-21

Locations

1 site across 1 country: Egypt